Abstract
Juvenile Idiopathic Arthritis (JIA) is the most common form of chronic arthritis in children and an important cause of both the short term and long term morbidities. JIA is the new terminology proposed by the International League of Associations of Rheumatologists (ILAR). Three separate systems are used currently to classify chronic arthritis in children. These are American College of Rheumatology (ACR) classification, The European League against Rheumatism (EULAR) classification and ILAR classification. The diagnosis of JIA remains a clinical one, and is essentially one of exclusion in addition to suspicion and recognition of patterns. There is no single test for the diagnosis of JIA. The treatment of JIA is rapidly changing. Aims of good management of JIA include: controlling pain and inflammation, preserving function and promoting normal growth and development. Remarkable advances have been made in the management of JIA with the advent of new modalities of treatment. Effective management of JIA needs a multidisciplinary team approach. Even after effective management, about one-third of JIA patients continue to manifest their disease activity into adulthood with serious morbidity and disabilities. DOI: 10.3329/jbcps.v27i2.4252 J Bangladesh Coll Phys Surg 2009; 27: 91-98
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Bangladesh College of Physicians and Surgeons
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
